Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $34.64 +3.59%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Susquehanna lowered its price target on Teva Pharma (NYSE: TEVA) to $14.00 (from $20.00) while maintaining a Positive rating.
Analyst Andrew Finkelstein notes Q3 showed further challenges.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Susquehanna Downgrades Greenbrier Companies (GBX) to Neutral
- Coca-Cola Hellenic (CCH:LN) (CCHGY) PT Raised to GBP56 at UBS
- Integrafin Holdings Plc (IHP:LN) PT Raised to GBP4.75 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
